Found: 45
Select item for more details and to access through your institution.
Challenges in measuring and valuing productivity costs, and their relevance in mood disorders.
- Published in:
- ClinicoEconomics & Outcomes Research, 2013, v. 5, p. 565, doi. 10.2147/CEOR.S44866
- By:
- Publication type:
- Article
Do different clinical evidence bases lead to discordant health-technology assessment decisions? An in-depth case series across three jurisdictions.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Assessing the quality of Swedish health economics research.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Value Insider Season 1 Episode 1: The Importance of Payers and HTA: How Did We End Up Here? (Introduction to Value) [Podcast].
- Published in:
- International Journal of General Medicine, 2022, v. 15, p. 7487, doi. 10.2147/IJGM.S389025
- By:
- Publication type:
- Article
Modelling in economic evaluation: an unavoidable fact of life.
- Published in:
- 1997
- By:
- Publication type:
- editorial
A final comment.
- Published in:
- European Journal of Health Economics, 2002, v. 3, n. 2, p. 142, doi. 10.1007/s10198-002-0124-7
- By:
- Publication type:
- Article
Time for a change in drug licensing requirements?
- Published in:
- European Journal of Health Economics, 2002, v. 3, n. 2, p. 137, doi. 10.1007/s10198-002-0119-4
- By:
- Publication type:
- Article
Modeling in Early Stages of Technology Development: Is an Iterative Approach Needed? Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling".
- Published in:
- International Journal of Health Policy & Management, 2020, v. 9, n. 6, p. 260, doi. 10.15171/ijhpm.2019.118
- By:
- Publication type:
- Article
Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations?
- Published in:
- International Journal of Technology Assessment in Health Care, 2010, v. 26, n. 1, p. 71, doi. 10.1017/S0266462309990833
- By:
- Publication type:
- Article
Key principles for the improved conduct of health technology assessments for resource allocation decisions.
- Published in:
- International Journal of Technology Assessment in Health Care, 2008, v. 24, n. 3, p. 244, doi. 10.1017/S0266462308080343
- By:
- Publication type:
- Article
Systematic reviews and economic evaluations conducted for the National Institute for Health and Clinical Excellence in the United Kingdom: A game of two halves?
- Published in:
- International Journal of Technology Assessment in Health Care, 2008, v. 24, n. 2, p. 146, doi. 10.1017/S0266462308080203
- By:
- Publication type:
- Article
Increasing decision-makers' access to economic evaluations: Alternative methods of communicating the information.
- Published in:
- International Journal of Technology Assessment in Health Care, 2008, v. 24, n. 2, p. 151, doi. 10.1017/S0266462308080215
- By:
- Publication type:
- Article
Assessing the economic challenges posed by orphan drugs.
- Published in:
- International Journal of Technology Assessment in Health Care, 2007, v. 23, n. 1, p. 36, doi. 10.1017/S0266462307051550
- By:
- Publication type:
- Article
Health-care decision-making processes in Latin America: problems and prospects for the use of economic evaluation.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Analyzing differences in the costs of treatment across centers within economic evaluations.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Users' guides to the medical literature.
- Published in:
- JAMA: Journal of the American Medical Association, 1997, v. 277, n. 19, p. 1552, doi. 10.1001/jama.1997.03540430064035
- By:
- Publication type:
- Article
Cost‐effectiveness analysis of oxaliplatin compared with 5‐fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the USThis study was carried out by i3 Innovus under a grant from Sanofi‐Aventis. Sanofi‐Aventis provided the raw MOSAIC dataset and reviewed article drafts; i3 Innovus carried out all analyses and interpreted data and results independently.
- Published in:
- Cancer (0008543X), 2007, v. 109, n. 6, p. 1082
- By:
- Publication type:
- Article
Cost-effectiveness in the diagnosis and treatment of carcinoma of unknown primary origin.
- Published in:
- Canadian Medical Association Journal (CMAJ), 1985, v. 133, n. 10, p. 977
- By:
- Publication type:
- Article
An Economic Comparison of Influenza Vaccines Recommended for Use in Eligible Adults under 65 Years in the United Kingdom.
- Published in:
- Vaccines, 2022, v. 10, n. 4, p. N.PAG, doi. 10.3390/vaccines10040599
- By:
- Publication type:
- Article
The Cost-Effectiveness of Expanding Vaccination with a Cell-Based Influenza Vaccine to Low Risk Adults Aged 50 to 64 Years in the United Kingdom.
- Published in:
- Vaccines, 2021, v. 9, n. 6, p. 598, doi. 10.3390/vaccines9060598
- By:
- Publication type:
- Article
Switching Therapy in Health Economics Trials: Confronting the Confusion.
- Published in:
- Medical Decision Making, 2003, v. 23, n. 4, p. 335, doi. 10.1177/0272989X03256007
- By:
- Publication type:
- Article
Willingness to Pay for What? A Note on Alternative Definitions of Health Care Program Benefits for Contingent Valuation Studies.
- Published in:
- Medical Decision Making, 2002, v. 22, n. 6, p. 493, doi. 10.1177/0272989X02238301
- By:
- Publication type:
- Article
Willingness to Pay for What? A Note on Alternative Definitions of Health Care Program Benefits for Contingent Valuation Studies.
- Published in:
- Medical Decision Making, 2002, v. 22, n. 6, p. 462, doi. 10.1177/0272989x02238301
- By:
- Publication type:
- Article
Experimental versus Observational Data in the Economic Evaluation of Pharmaceuticals.
- Published in:
- Medical Decision Making, 1998, v. 18, n. 2S, p. S12, doi. 10.1177/0272989X9801800203
- By:
- Publication type:
- Article
Experimental versus Observational Data in the Economic Evaluation of Pharmaceuticals.
- Published in:
- Medical Decision Making, 1998, v. 18, n. 2, p. S12, doi. 10.1177/0272989X9801800203
- By:
- Publication type:
- Article
Selection of End Points in Economic Evaluations of Coronary-heart-disease Interventions.
- Published in:
- Medical Decision Making, 1993, v. 13, n. 3, p. 184, doi. 10.1177/0272989X9301300303
- By:
- Publication type:
- Article
Using QALYs in Cancer: A Review of the Methodological Limitations.
- Published in:
- PharmacoEconomics, 2011, v. 29, n. 8, p. 673, doi. 10.2165/11588250-000000000-00000
- By:
- Publication type:
- Article
Guidelines for conducting pharmaceutical budget impact analyses for submission to public drug plans in Canada.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Analysis sans frontières: can we ever make economic evaluations generalisable across jurisdictions?
- Published in:
- 2006
- By:
- Publication type:
- journal article
Analysis Sans Frontières: Can We Ever Make Economic Evaluations Generalisable Across Jurisdictions?
- Published in:
- PharmacoEconomics, 2006, v. 24, n. 11, p. 1087, doi. 10.2165/00019053-200624110-00006
- By:
- Publication type:
- Article
Better analysis for better decisions: facing up to the challenges.
- Published in:
- 2006
- By:
- Publication type:
- editorial
Education in pharmacoeconomics: an international multidisciplinary view.
- Published in:
- 2004
- By:
- Publication type:
- journal article
International lessons in new methods for grading and integrating cost effectiveness evidence into clinical practice guidelines.
- Published in:
- Cost Effectiveness & Resource Allocation, 2017, v. 15, p. 1, doi. 10.1186/s12962-017-0063-x
- By:
- Publication type:
- Article
Medication management in English National Health Service hospitals.
- Published in:
- American Journal of Health-System Pharmacy, 2005, v. 62, n. 2, p. 189.
- By:
- Publication type:
- Article
Trials and tribulations. Emerging issues in designing economic evaluations alongside clinical trials.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Economic analysis alongside clinical trials. Bias in the assessment of economic outcomes.
- Published in:
- 1996
- By:
- Publication type:
- journal article
A multinational economic evaluation of rhDNase in the treatment of cystic fibrosis.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Issues in the Cross-National Assessment of Health Technology.
- Published in:
- International Journal of Technology Assessment in Health Care, 1992, v. 8, n. 4, p. 670, doi. 10.1017/S0266462300002361
- By:
- Publication type:
- Article
Economic analysis alongside clinical trials. Revisiting the methodological issues.
- Published in:
- 1991
- By:
- Publication type:
- journal article
Economic evaluation of a support program for caregivers of demented elderly.
- Published in:
- 1991
- By:
- Publication type:
- journal article
Allocating resources.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Is Prevention Better Than Cure?
- Published in:
- International Journal of Technology Assessment in Health Care, 1987, v. 3, n. 2, p. 329, doi. 10.1017/S0266462300000647
- By:
- Publication type:
- Article
The ethics and feasibility of randomized trials of diagnostic technology: a reply.
- Published in:
- 1985
- By:
- Publication type:
- journal article
Guidelines for Health Technology Assessment.
- Published in:
- International Journal of Technology Assessment in Health Care, 1985, v. 1, n. 4, p. 873, doi. 10.1017/S0266462300001859
- By:
- Publication type:
- Article
Economic Evaluation of Treatment Strategies in Gastroenterology.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 2005, v. 100, n. 10, p. 2143, doi. 10.1111/j.1572-0241.2005.00299.x
- By:
- Publication type:
- Article